New Taipei, Taiwan In 2015 was created Pacific 8 Ventures, which is appeared as VC. The company was established in Asia in Taiwan. The leading representative office of defined VC is situated in the Taipei.
The important activity for fund was in 2017. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 deals per year.
The fund was created by Chris Shu, Jack Liang, Ser-Chen Fu. The overall number of key employees were 3.
Among the various public portfolio startups of the fund, we may underline Karius, Multiply Labs, Fauna Bio For fund there is no match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Mobile, SaaS. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Pacific 8 Ventures, startups are often financed by Y Combinator, Three Leaf Ventures, StartUp Health. The meaningful sponsors for the fund in investment in the same round are aMoon Fund, Three Leaf Ventures, StartX (Stanford-StartX Fund). In the next rounds fund is usually obtained by Y Combinator, Webb Investment Network, Tom Williams.
Related Funds
| Fund Name | Location |
| Accelerate Venture Partners | Kansas, United States, Wichita |
| Adobe Fund for Design | - |
| Axcel Partners | Maryland, Stevenson, United States |
| Base Pair Canada | - |
| Chicago Title Insurance Company | Florida, Jacksonville, United States |
| CommonSpirit | Chicago, Illinois, United States |
| Huff Alternative | Morristown, New Jersey, United States |
| Lennar Ventures | - |
| New Hampshire Innovation Research Center | Durham, New Hampshire, United States |
| Perle Ventures | Australia, New South Wales, Sydney |
| Prive Financial | China, Hong Kong, Hong Kong Island |
| Profectus Capital | India, Maharashtra, Mumbai |
| Quest International Management | California, Torrance, United States |
| Sandbox VR | California, San Mateo, United States |
| Shanghai Chenma | China, Shanghai, Shanghai |
| Syskoplan | - |
| tecTerra | Alberta, Calgary, Canada |
| Xingzheng Touzi | China, Shanghai |
| Yamaguchi Financial Group | Japan, Shimonoseki, Yamaguchi Prefecture |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Certainly Health | $2M | 13 Dec 2023 | New York, New York, United States | ||
BillionToOne | $125M | 30 Mar 2022 | California, United States | ||
Fauna Bio | $9M | 21 Sep 2021 | Berkeley, California, United States | ||
Bunkerhill Health | 01 Dec 2020 | Palo Alto, California, United States | |||
BillionToOne | $15M | 10 Mar 2020 | California, United States | ||
hi.health | $3M | 04 Feb 2020 | Vienna, Austria | ||
Mammoth Biosciences | $45M | 30 Jan 2020 | San Francisco, California, United States | ||
Fauna Bio | $4M | 11 Apr 2019 | Berkeley, California, United States | ||
Hint Health | $10M | 08 May 2018 | San Francisco, California, United States |
– Fauna Bio is an Emeryville, California-based biotechnology company leveraging animal genomics to improve human health.
– The company raised $9m in Seed funding.
– The round was led by LifeForce Capital with participation from True Ventures, Boom Capital, Pacific 8 Ventures, BioMed Ventures, Vibe Capital and Arcadia Science.
– The new investment will be used to expand its drug discovery platform Convergence while accelerating the discovery of new therapeutic targets for human diseases across a broad range of indications.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Certainly Health | $2M | 13 Dec 2023 | New York, New York, United States | ||
BillionToOne | $125M | 30 Mar 2022 | California, United States | ||
Fauna Bio | $9M | 21 Sep 2021 | Berkeley, California, United States | ||
Bunkerhill Health | 01 Dec 2020 | Palo Alto, California, United States | |||
BillionToOne | $15M | 10 Mar 2020 | California, United States | ||
hi.health | $3M | 04 Feb 2020 | Vienna, Austria | ||
Mammoth Biosciences | $45M | 30 Jan 2020 | San Francisco, California, United States | ||
Fauna Bio | $4M | 11 Apr 2019 | Berkeley, California, United States | ||
Hint Health | $10M | 08 May 2018 | San Francisco, California, United States |
